NYCSHP and Royals Chapter held their second collaborative networking meeting at the Wythe Hotel in Williamsburg. Health care professionals gathered together to network. Pharmacy residents, in particular, were able to meet and network amongst the different health care systems in the NYC, Brooklyn, Long Island regions.
The speaker was Mary Lynn Moody, BSPharm, the Assistant Dean of Business Development and Clinical Associate Professor at the University of Illinois at Chicago College of Pharmacy. Professor Moody has been actively involved in working with organizations, including ASHP and ISMP, to improve the safety and delivery of intravenous medications as well as has been publishing literature in this field.
Professor Moody focused on the diagnosis and treatment of two rare blood disorders: acquired hemophilia A and congenital protein C deficiency. Acquired hemophilia A (AHA) is a rare bleeding condition caused by autoantibody inhibitor to coagulation factor VIII. AHA generally presents in the elderly population and is idiopathic in nature. OBIZUR is an antihemophilic factor (recombinant) porcine sequence that temporarily replaces inhibited endogenous factor VIII.
Congenital protein C deficiency is a rare blood disorder that predisposes infants to thrombotic events. Protein C is an important natural anticoagulant that downregulates the coagulation cascade by inactivating coagulation factor Va and VIIIa. One of the treatment options for congenital protein C deficiency is LEPROTIN, a protein C concentrate. After a wonderful lecture about new agents used to replenish patient with hematologic disorders, there was a question and answer session.
Article by Peter Hoang and Jamie Chin
Photos by Gretchen Marcelino and Jamie Chin